Starbucks (SBUX)
(Real Time Quote from BATS)
$77.10 USD
-2.17 (-2.74%)
Updated Jul 22, 2024 09:38 AM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Price, Consensus and EPS Surprise
SBUX 77.10 -2.17(-2.74%)
Will SBUX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SBUX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SBUX
Starbucks (SBUX) Soars 6.9%: Is Further Upside Left in the Stock?
Starbucks (SBUX) Stock Moves -0.54%: What You Should Know
SBUX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Starbucks (SBUX) Stock Dips While Market Gains: Key Facts
Here's Why You Should Retain Starbucks (SBUX) Stock Now
Investors Heavily Search Starbucks Corporation (SBUX): Here is What You Need to Know
Other News for SBUX
Starbucks price target lowered by $20 at BMO Capital, here's why
Analysts expect Starbucks to benefit from Elliott Management's involvement
Four Stocks To Watch This Week - Monday, July 22
Activist Investor Influence: A Catalyst for Starbucks’ Strategic and Financial Enhancement
Buy Rating Affirmed for Starbucks Amidst Potential Strategic Enhancements and Growth Opportunities